Response Genetics Announces Proposed Public Offering

Response Genetics

announced today it intends to offer and sell registered shares of its common stock in an underwritten public offering. The Company expects to use the net proceeds of the offering for working capital and general corporate purposes.  National Securities Corporation, a wholly owned subsidiary of National Holdings, Inc.

, is serving as the sole underwriter of the offering.